# Copper-64

Type: Technology

Source: GetYourBrief — https://getyourbrief.com/entity/copper-64
Canonical HTML page: https://getyourbrief.com/entity/copper-64

## Timeline

- **2027**: Phase III Milestones — Anticipated data readouts for TCT imaging agents supported by Cu-64 supply.
- **2026-Q4**: Supply Chain Integration — Integration of Theragenics' output into Clarity's clinical trial logistics.
- **2026-Q3**: Production Ramp-up — Expected commencement of large-scale isotope production for late-stage clinical trials.
- **2026-Q2**: Process Integration — Technical teams begin integrating manufacturing protocols and quality control standards.
- **2026-03-25**: Agreement Signed — Clarity and Theragenics formalize the large-scale manufacturing supply deal for Cu-64.
- **2026-03-25**: Supply Agreement Signed — Clarity and Theragenics formalize large-scale Cu-64 manufacturing partnership.

## Recent coverage (3 stories, network-wide)

### Clarity Secures Large-Scale Cu-64 Supply Agreement with Theragenics
2026-03-25 18:09:08 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 2

Clarity Pharmaceuticals has signed a major manufacturing supply agreement with Theragenics to secure large-scale production of copper-64. This partnership bolsters the supply chain for Clarity’s Targeted Copper Theranostics platform as it moves toward late-stage clinical trials.
Full story: https://getbiobrief.com/story/clarity-theragenics-copper-64-supply-agreement

### Clarity Pharmaceuticals Secures Scalable Cu-64 Supply via Theragenics Deal
2026-03-25 18:09:03 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2

Clarity Pharmaceuticals has entered into a multi-year manufacturing supply agreement with Theragenics for the production of copper-64 (Cu-64). This partnership secures a reliable, large-scale supply of the isotope to support Clarity's clinical trials and future commercialization of its Targeted Copper Theranostics platform.
Full story: https://gethealthbrief.com/story/clarity-theragenics-cu64-supply-deal

### Clarity and Theragenics Ink Major Copper-64 Manufacturing Supply Deal
2026-03-25 18:03:53 · Sector: supply · Sentiment: Positive · Impact: 6/10 · Sources: 2

Clarity Pharmaceuticals has secured a large-scale manufacturing supply agreement with Theragenics for the production of copper-64. This strategic partnership addresses critical supply chain bottlenecks for radiopharmaceuticals, ensuring a reliable flow of isotopes for Clarity’s diagnostic and therapeutic clinical trials.
Full story: https://getsupplybrief.com/story/clarity-theragenics-copper-64-manufacturing-agreement

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.